These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32079461)

  • 1. 18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma.
    Mapelli P; Picchio M
    Int J Biol Markers; 2020 Feb; 35(1_suppl):42-46. PubMed ID: 32079461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers.
    Mapelli P; Callea M; Fallanca F; Castellano A; Bailo M; Scifo P; Bettinardi V; Conte GM; Monterisi C; Rancoita PMV; Incerti E; Vuozzo M; Gianolli L; Terreni M; Anzalone N; Picchio M
    Nucl Med Commun; 2021 Jul; 42(7):763-771. PubMed ID: 33741855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.
    Bekaert L; Valable S; Lechapt-Zalcman E; Ponte K; Collet S; Constans JM; Levallet G; Bordji K; Petit E; Branger P; Emery E; Manrique A; Barré L; Bernaudin M; Guillamo JS
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1383-1392. PubMed ID: 28315948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy.
    Mapelli P; Zerbetto F; Incerti E; Conte GM; Bettinardi V; Fallanca F; Anzalone N; Di Muzio N; Gianolli L; Picchio M
    Clin Nucl Med; 2017 Dec; 42(12):e525-e526. PubMed ID: 29035992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.
    Stieb S; Eleftheriou A; Warnock G; Guckenberger M; Riesterer O
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2201-2217. PubMed ID: 30128659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas.
    Yamamoto Y; Maeda Y; Kawai N; Kudomi N; Aga F; Ono Y; Nishiyama Y
    Nucl Med Commun; 2012 Jun; 33(6):621-5. PubMed ID: 22422099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia and Amino Acid Imaging of High-Grade Glioma: 18F-FAZA PET/CT and 11C-Methionine PET/MRI.
    Mapelli P; Fallanca F; Scifo P; Barbera M; Castellano A; Bettinardi V; Incerti E; Gianolli L; Anzalone N; Picchio M
    Clin Nucl Med; 2020 Jun; 45(6):e290-e293. PubMed ID: 32332306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic Evaluation of the Hypoxia Radiotracers [
    Choen S; Kent MS; Chaudhari AJ; Cherry SR; Krtolica A; Zwingenberger AL
    Nucl Med Mol Imaging; 2023 Feb; 57(1):16-25. PubMed ID: 36643946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing hypoxia in human glioma: A simultaneous multimodal MRI and PET study.
    Preibisch C; Shi K; Kluge A; Lukas M; Wiestler B; Göttler J; Gempt J; Ringel F; Al Jaberi M; Schlegel J; Meyer B; Zimmer C; Pyka T; Förster S
    NMR Biomed; 2017 Nov; 30(11):. PubMed ID: 28805936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
    Yamaguchi S; Hirata K; Toyonaga T; Kobayashi K; Ishi Y; Motegi H; Kobayashi H; Shiga T; Tamaki N; Terasaka S; Houkin K
    PLoS One; 2016; 11(12):e0167917. PubMed ID: 27936194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head and neck tumor hypoxia imaging by 18F-fluoroazomycin-arabinoside (18F-FAZA)-PET: a review.
    Halmos GB; Bruine de Bruin L; Langendijk JA; van der Laan BF; Pruim J; Steenbakkers RJ
    Clin Nucl Med; 2014 Jan; 39(1):44-8. PubMed ID: 24152663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between hypoxic area in primary brain tumors and WHO grade: differentiation from malignancy using 18F-fluoromisonidazole positron emission tomography.
    Kanoto M; Kirii K; Hiraka T; Toyoguchi Y; Sugai Y; Matsuda K; Sakurada K; Sonoda Y; Hatazawa J; Hosoya T
    Acta Radiol; 2018 Feb; 59(2):229-235. PubMed ID: 28534419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
    Cher LM; Murone C; Lawrentschuk N; Ramdave S; Papenfuss A; Hannah A; O'Keefe GJ; Sachinidis JI; Berlangieri SU; Fabinyi G; Scott AM
    J Nucl Med; 2006 Mar; 47(3):410-8. PubMed ID: 16513609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β -[
    Kumar P; Roselt P; Reischl G; Cullinane C; Beiki D; Ehrlichmann W; Binns D; Naimi E; Yang J; Hicks R; Machulla HJ; Wiebe LI
    Curr Radiopharm; 2017; 10(2):93-101. PubMed ID: 28294075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques.
    Garcia-Parra R; Wood D; Shah RB; Siddiqui J; Hussain H; Park H; Desmond T; Meyer C; Piert M
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1816-23. PubMed ID: 21833840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [
    Gammon ST; Pisaneschi F; Bandi ML; Smith MG; Sun Y; Rao Y; Muller F; Wong F; De Groot J; Ackroyd J; Mawlawi O; Davies MA; Gopal YNV; Di Francesco ME; Marszalek JR; Dewhirst M; Piwnica-Worms D
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?
    Unterrainer M; Schweisthal F; Suchorska B; Wenter V; Schmid-Tannwald C; Fendler WP; Schüller U; Bartenstein P; Tonn JC; Albert NL
    J Nucl Med; 2016 Aug; 57(8):1177-82. PubMed ID: 27033893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
    Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
    Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma.
    Shaw TB; Jeffree RL; Thomas P; Goodman S; Debowski M; Lwin Z; Chua B
    J Med Imaging Radiat Oncol; 2019 Oct; 63(5):650-656. PubMed ID: 31368665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.